Cocrystal Pharma, Inc. (COCP) Financials
COCP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 32.6 million | 1.9 million |
| 2023-06-30 | 36.3 million | 1.6 million |
| 2023-03-31 | 37.8 million | 3.2 million |
| 2022-12-31 | 40.8 million | 1.3 million |
COCP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.7 million | 173000 |
| 2023-06-30 | -5.6 million | 179000 |
| 2023-03-31 | -3.2 million | 291000 |
| 2022-12-31 | -4.9 million | 159000 |
COCP Net Income
No data available :(
COCP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 29.7 million | - | 118000 |
| 2023-06-30 | 32.4 million | - | 176000 |
| 2023-03-31 | 34.0 million | - | 235000 |
| 2022-12-31 | 37.1 million | - | 297000 |
COCP Shares Outstanding
COCP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 1543 | 4.2 million | 1.8 million | - |
| 2023-06-30 | 14000 | 2.8 million | 1.5 million | - |
| 2023-03-31 | 45000 | 3.9 million | 1.2 million | - |
| 2022-12-31 | 12000 | 3.3 million | 1.2 million | - |
COCP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 108000 |
| 2023-06-30 | - | 101000 |
| 2023-03-31 | - | 103000 |
| 2022-12-31 | - | 241600 |
COCP
Price: $1.57
52 week price:
Earnings Per Share: -1.97 USD
P/E Ratio: -0.79
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 92200
Market Capitalization: 15.8 million